Overexpression of glycosylated proteins in cervical cancer recognized by the Machaerocereus eruca agglutinin

Folia Histochemica et Cytobiologica

Volumn 50, Issue 3, 2012, Pages 398-406

  Solórzano, Carlos ^a,b   Mayoral, Miguel Ángel ^b   Carlos, María de los Angeles ^c   Berumen, Jaime ^c   Guevara, Jorge ^a   Chávez, Francisco Raúl ^a   Mendoza Hernández, Guillermo ^a   Agundis, Concepción ^a   Zenteno, Edgar ^a,b  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b Centro Multidisciplinario de Investigación UNAM UABJO   (Mexico)

^c SECRETARÍA DE SALUD   (Mexico)

Author keywords

Amaranthus leucocarpus; Cervical cancer; Lectins; Machaerocereus eruca; Mucin; O glycosylation

Indexed keywords

AGGLUTININ; BETA ACTIN; CYTOKERATIN 1; ELONGATION FACTOR 2; GLYCOSYLATED PROTEIN; LAMIN A; LAMIN C; LECTIN; MUCIN; TRYPSIN; VIMENTIN;

AMINO ACID SEQUENCE; ARTICLE; CACTACEAE; CANCER INVASION; CANCER LOCALIZATION; CANCER STAGING; CONTROLLED STUDY; DNA SEQUENCE; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; MACHAEROCEREUS ERUCA; MOLECULAR INTERACTION; MOLECULAR PATHOLOGY; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; TUMOR BIOPSY; TWO DIMENSIONAL ELECTROPHORESIS; UTERINE CERVIX CANCER; WESTERN BLOTTING;

EID: 84867834136     PISSN: 02398508     EISSN: 18975631     Source Type: Journal    
DOI: 10.5603/FHC.2012.0054     Document Type: Article

References (53)

1. Brockhausen I. Pathways of O-glycan biosynthesis in cancer cells. Biochim Biophys Acta. 1999;1473: 67-95.
2. Hakomori S. Glycosylation defining cancer malignancy: New wine in an old bottle. Proc Natl Acad Sci USA. 2002;99:10231-10233.
3. Kreunin P, Zhao J, Rosser C, Urquidi V, Lubman DM, Goodison S. Bladder cancer associated glycoprotein signatures revealed by urinary proteomic profiling. J Proteome Res. 2007;6:2631-2639.
4. Higai K, Ishihara S, Matsumoto K. NFkappaB-p65 dependent transcriptional regulation of glycosyltransferases in human colon adenocarcinoma HT-29 by stimulation with tumor necrosis factor alpha. Biol Pharm Bull. 2006;29: 2372-2377.
5. Gu C, Oyama T, Osaki T et al. Low expression of polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in lung adenocarcinoma: impact on poor prognosis and early recurrence. Br J Cancer. 2004;90:436-442.
6. Blonski K, Milde-Langosch K, Bamberger AM et al. Ulex europeus agglutinin-I binding as a potential prognostic marker in ovarian cancer. Anticancer Res. 2007;27:2785-2790.
7. Dwek MV, Jenks A, Leathem AJ. A sensitive assay to measure biomarker glycosylation demonstrates increased fucosylation of prostate specific antigen (PSA) in patients with prostate cancer compared with benign prostatic hyperplasia. Clin Chim Acta. 2010; 411:1935-1939.
8. Metoki R, Kakudo K, Tsuji Y, Teng N, Clausen H, Hakomori S. Deletion of histo-blood group A and B antigens and expression of incompatible A antigen in ovarian cancer. J Natl Cancer Inst. 1989;81:1151-1157.
9. Chammas R, Sonnenburg JL, Watson NE et al. De-N-acetylgangliosides in humans: unusual subcellular distribution of a novel tumor antigen. Cancer Res. 1989;59:1337-1346.
10. Couldrey C, Green JE. Metastases: the glycan connection. Breast Cancer Res. 2000;2:321-323.
11. Gorelik E, Galili U, Raz A. On the role of cell surface carbohydrates and their binding proteins (lectins) in tumor metastasis. Cancer Metastasis Rev. 2001;20:245-277.
12. Springer GF. T and Tn pancarcinoma markers: autoantigenic adhesion molecules in pathogenesis, prebiopsy carcinoma- detection, and long-term breast carcinoma immunotherapy. Crit Rev Oncogenesis. 1995;6:57-85.
13. Lis H, Sharon N. Lectins as molecules and as tools. Ann Rev Biochem. 1986;55:35-67.
14. Santaella A, Gallegos B, Perez-Campos E, Zenteno E, Hernández P. Use of Amaranthus leucocarpus lectin to differentiate cervical dysplasia (CIN). Prep Biochem Biotechnol. 2007;37:219-228.
15. Kohrenhagen N. Volker HU, Kapp M, Dietl J, Kammerer U. Increased expression of galectin-1 during the progression of cervical neoplasia. Int J Gynecol Cancer. 2006;16:2018-2022.
16. Zenteno E, Ochoa JL. Isolation and characterization of Amaranthus leucocarpus lectin. Phytochemistry. 1998;27:313-317.
17. Zenteno E, Debray H, Montreuil J. Purification and partial characterization of two lectins from the cactus Machaerocereus eruca. FEBS Letters. 1988;238:95-100.
18. Savage D, Mattson G, Desai S, Nielander G, Morgensen S, Coklin E. Avidin-biotin chemistry: a handbook. Rockford IL Pierce Chemical Co.; 1992.
19. Zenteno E, Vazquez L, Chavez R et al. Specificity of the isolectins from the plant cactus Machaerocereus eruca for oligosaccharides from porcine stomach mucin. Glycoconj J. 1995;12:699-706.
20. Mayoral MA, Mayoral C, Rembao D et al. Identification of Galectin-3 and Mucin-type O-glycans in breast cancer and its metastasis to brain. Cancer Invest. 2008;26:615-623.
21. Towbin M, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrilamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA. 1979;76:4350-4354.
22. Peterson GL. A simplification of the protein assay method which is more generally applicable. Anal Biochem. 1977;83:346-356.
23. Findlay JBC, Pappin D, Keen J. Automated solid-phase micro sequencing. In Finldaly (Ed), Protein sequencing, JBC 1989. IRL Press-Oxford University Press UK.
24. López-Ferrer A, Barranco C, de Bolos C. Differences in the O-glycosylation patterns between lung squamous cell carcinoma and adenocarcinoma. Am J Clin Pathol. 2002;118:749-755.
25. Van den Steen P, Rudd PM, Dwek RA, Openakker G. Concepts and principles of O-linked glycosylation. Crit Rev Biochem Mol Biol. 1988;33:151-208.
26. Martensson S, Levery SB, Fang TT, Bendiak B. Neutral core oligosaccharides of bovine submaxillary mucin: use of lead tetraacetate in the cold for establishing branch positions. Eur J Biochem. 1998;258:603-622.
27. Lotan R, Skutelsky E, Danon D, Sharon N. The purification, composition and specificity of the anti-T lectin from peanut (Arachis hypogaea). J Biol Chem. 1975;250: 8518-8523.
28. Hernandez P, Tetaert D, Vergoten G et al. Specificity of Amaranthus leucocarpus syn hypocondriacus lectin for O-glycopeptides. Biochim Biophys Acta. 2004;1674:282-290.
29. Weiss I, Drickramer K. Structural basis of the lectin-carbohydrate recognition. Annu Rev Biochem. 1996; 65:441-473.
30. Sharma V, Surolia A. Analysis of carbohydrate recognition by legume lectin: Size of the combining site loops and their primary specificity. J Mol Biol. 1997;267:433-445.
31. Vijayan M, Chadra N. Lectins. Curr Op Struc Biol. 1999;9:704-714.
32. Clausen H, Hakomori S. ABH and related histo-blood group antigens; immunochemical differences in carrier isotypes and their distribution. Vox Sang. 1989;56:1-20.
33. Laferte S, Chan NW, Sujino K, Lowary TL, Palcic MM. Intracellular inhibition of blood group A glycosyltransferase. Eur J Biochem. 2000;267:4840-4849.
34. Wang PH, Lee WL, Lee YR et al. Enhanced expression of a 2,6-sialyltransferase ST6Gal I in cervical squamous cellcarcinoma. Gynecol Oncology. 2003;89:395-401.
35. Hernandez L, Roux KJ, Wong ES. Functional coupling between the extracellular matrix and nuclear lamina by Wnt signaling in progeria. Dev Cell. 2010;19:41-425.
36. Dey P. Nuclear margin irregularity and cancer: a review. Anal Quant Cytol Histol. 2009;31:345-352.
37. Han CP, Lee MY, Tyan YS et al. p16 INK4 and CEA can be mutually exchanged with confidence between both relevant three-marker panels (ER/Vim/CEA and ER/Vim/p16 INK4) in distinguishing primary endometrial adenocarcinomas from endocervical adenocarcinomas in a tissue microarray study. Vimentin Virchows Arch. 2009;455:353-361.
38. Lee MY, Chou CY, Tang MJ, Shen MR. Epithelial-mesenchymal transition in cervical cancer: correlation with tumor progression, epidermal growth factor receptor overexpression, and snail up-regulation. Clin Cancer Res. 2008;14:4743-4750.
39. Stewart CJ, Little L. Diagnostic value and implications of vimentin expression in normal, reactive and neoplastic endocervical epithelium. Pathology. 2010;42:217-223.
40. Korita PV, Wakai T, Ajioka Y et al. Aberrant expression of vimentin correlates with dedifferentiation and poor prognosis in patients with intrahepatic cholangiocarcinoma. Anticancer Res. 2010;30:2279-2285.
41. Sahab ZJ, Hall MD, Zhang L, Cheema AK, Byers SW. Tumor Suppressor RARRES1 regulates DLG2, PP2A, VCP, EB1, and Ankrd26. J Cancer. 2010;1:4-22.
42. Scurr LL, Guminski AD, Chiew YE et al. Ankyrin repeat domain 1, ANKRD1, a novel determinant of cispl atin sensitivity expressed in ovarian cancer. Clin Cancer Res. 2008;14:6924-6932.
43. Lee MY, Chou CY, Tang MJ, Shen MR. Epithelial-mesenchymal transition in cervical cancer: correlation with tumor progression, epidermal growth factor receptor overexpression, and snail up-regulation. Clin Cancer Res. 2008;14:4743-4750.
44. Bera TK, Saint Fleur A, Ha D et al. Selective POTE paralogs on chromosome 2 are expressed in human embryonic stem cells. Stem Cells Dev. 2008;17:325-332.
45. Chang KW, Yang PY, Lai HY, Yeh TS, Chen TC, Yeh CT. Identification of a novel actin isoform in hepatocellular carcinoma. Hepatol Res. 2006;36:33-39.
46. Julenius K, Mřlgaard A, Gupta R, Brunak S. Prediction, conservation analysis and structural characterization of mammalian mucin-type O-glycosylation sites. Glycobiology. 2005;15:153-164.
47. Suzuki A, Iizuka A, Komiyama M et al. Identification of melanoma antigens using a Serological Proteome Approach (SERPA). Cancer Genomics Proteomics. 2010;17:17-23.
48. Nakamura J, Aoyagi S, Nanchi I et al. Overexpression of eukaryotic elongation factor eEF2 in gastrointestinal cancers and its involvement in G2/M progression in the cell cycle. Int J Oncol. 2009;34:1181-1189.
49. Ambrosino C, Tarallo R, Bamundo A et al. Identification of a hormone-regulated dynamic nuclear actin network associated with estrogen receptor alpha in human breast cancer cell nuclei. Mol Cell Proteomics. 2010;9:1352-1367.
50. Rajpert-De Meyts E, Poll SN et al. Changes in the profile of simple mucin-type O-glycans and polypeptide GalNAc-transferases in human testis and testicular neoplasms are associated with germ cell maturation and tumour differentiation. Virchows Arch. 2007;4:805-814.
51. Lee MY, Chou CY, Tang MJ, Shen MR. Epithelial-mesenchymal transition in cervical cancer: correlation with tumor progression, epidermal growth factor receptor overexpression, and snail up-regulation. Clin Cancer Res. 2008;14:4743-4750.
52. Plattner VE, Wagner M, Ratzinger G, Gabor F, Wirth M. Targeted drug delivery: binding and uptake of plant lectins using human 5637 bladder cancer cells. Eur J Pharm Biopharm. 2008;70:572-576.
53. Liu FT, Rabinovich GA. Galectins as modulators of tumour progression. Nat Rev Cancer. 2005;5:29-41.